TARGETED PROTEIN DEGRADATION
Kurt Gish, Ph.D., is CSO and Co-Founder of Trilo Therapeutics.
His presentation at the 2nd Annual Targeted Protein Degradation Summit
may be downloaded here.
Note, this presentation is intended for attendees only,
so please do not distribute or repost this copyrighted material.